Difference between revisions of "Team:HZAU-China/Safety"

 
(12 intermediate revisions by 5 users not shown)
Line 91: Line 91:
 
             z-index: 1;
 
             z-index: 1;
 
             background-color: #EEEEEE;
 
             background-color: #EEEEEE;
−
            opacity: 0.96;
 
−
            filter: alpha(opacity=96);
 
 
             box-shadow: 0 5px 15px #CCCCCC;
 
             box-shadow: 0 5px 15px #CCCCCC;
 
             display: none;
 
             display: none;
Line 154: Line 152:
 
         }
 
         }
  
−
         .daohang a:hover span{
+
         .daohang a:hover span {
−
             transform: rotateY(180deg);          
+
             transform: rotateY(180deg);
−
             -webkit-transform: rotateY(180deg);          
+
             -webkit-transform: rotateY(180deg);
−
             -moz-transform: rotateY(180deg);          
+
             -moz-transform: rotateY(180deg);
−
             -o-transform: rotateY(180deg);          
+
             -o-transform: rotateY(180deg);
 
             -ms-transform: rotateY(180deg);
 
             -ms-transform: rotateY(180deg);
−
             transition: all 0.5s ease-in-out;          
+
             transition: all 0.5s ease-in-out;
−
             -webkit-transition: all 0.5s ease-in-out;          
+
             -webkit-transition: all 0.5s ease-in-out;
−
             -moz-transition: all 0.5s ease-in-out;          
+
             -moz-transition: all 0.5s ease-in-out;
 
             -o-transition: all 0.5s ease-in-out;
 
             -o-transition: all 0.5s ease-in-out;
 
         }
 
         }
Line 248: Line 246:
 
         }
 
         }
  
−
         @media screen and (max-width: 880px) {
+
         @media screen and (max-width: 900px) {
  
 
             .daohang .caidan {
 
             .daohang .caidan {
Line 272: Line 270:
  
 
             .daohang .longName .item:before {
 
             .daohang .longName .item:before {
−
            width: 150px;
+
                width: 150px;
−
            left: 10px;
+
                left: 20px;
 
             }
 
             }
  
 
             .daohang .longName .item:hover:after {
 
             .daohang .longName .item:hover:after {
−
            width: 150px;
+
                width: 150px;
−
            left: 10px;
+
                left: 20px;
−
          }
+
            }
 
         }
 
         }
 
     </style>
 
     </style>
Line 302: Line 300:
 
             width: 80%;
 
             width: 80%;
 
             /* height: auto; */
 
             /* height: auto; */
−
             margin: 20px 20px 0 0;
+
             margin: 20px 40px 0 0;
 
             /* right: 2%; */
 
             /* right: 2%; */
 
             /* top: 90px; */
 
             /* top: 90px; */
−
             padding: 20px 3%;
+
             padding: 50px 3%;
 
             float: right;
 
             float: right;
 
             /* position: relative; */
 
             /* position: relative; */
Line 318: Line 316:
  
 
         .cebian {
 
         .cebian {
−
             width: 15%;
+
             width: 200px;
 
             /* height: 80vh; */
 
             /* height: 80vh; */
 
             float: left;
 
             float: left;
Line 327: Line 325:
 
             /* border:2px solid black */
 
             /* border:2px solid black */
 
             /* background-color: #323643 */
 
             /* background-color: #323643 */
 +
        }
 +
 +
        .zhengwen p{
 +
            text-align: justify !important;
 +
            font-family:  'Times New Roman',Helvetica,'Open Sans',  Arial, sans-serif !important;
 +
            color: #3B3B3B;
 +
            font-size: 26px !important;
 +
            padding-right: 20px;
 
         }
 
         }
  
Line 337: Line 343:
  
 
         .h1 {
 
         .h1 {
−
            height: 100px;
+
             line-height: 55px;
−
             line-height: 100px;
+
 
             font-weight: bold;
 
             font-weight: bold;
 +
            height:auto;
 
             font-family: 'Product Sans', sans-serif;
 
             font-family: 'Product Sans', sans-serif;
−
             font-size: 50px;
+
             font-size: 40px;
−
             color: black;
+
             color: #3B3B3B;
−
             border-bottom: 3px solid black;
+
             border-bottom: 2px solid #676767;
−
             /* margin: 0 2.4%; */
+
            margin-bottom: 20px;
 +
        }
 +
 
 +
        .h2 {
 +
            height: 40px;
 +
            line-height: 40px;
 +
            font-weight: bold;
 +
            height:auto;
 +
            /* font-weight: bold; */
 +
            font-family: 'Product Sans', sans-serif;
 +
            font-size: 30px;
 +
            color: #484848;
 +
             /* margin-bottom: 20px; */
 +
        }
 +
 
 +
        .h3 {
 +
            height: 30px;
 +
            line-height: 30px;
 +
            font-weight: bold;
 +
            height:auto;
 +
            /* font-weight: bold; */
 +
            font-family: 'Product Sans', sans-serif;
 +
            font-size: 24px;
 +
            color: #484848;
 +
            /* margin-bottom: 20px; */
 +
        }
 +
       
 +
        table {
 +
            color: #3B3B3B;
 
         }
 
         }
  
Line 462: Line 496:
  
 
         #float02 {}
 
         #float02 {}
−
 
−
        #float03 {}
 
  
 
         div.floatCtro {
 
         div.floatCtro {
 
             width: 100%;
 
             width: 100%;
−
             height: 250px;
+
             /* height: auto; */
 
             margin: 0;
 
             margin: 0;
 
             position: relative;
 
             position: relative;
Line 477: Line 509:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
−
             height: 40px;
+
             /* height: auto; */
 +
            /* text-align: left !important; */
 
             color: #ffffff !important;
 
             color: #ffffff !important;
 
             font-size: 16px;
 
             font-size: 16px;
 +
            padding:0;
 
             background-color: #323643;
 
             background-color: #323643;
 
             border-bottom: 1px solid black;
 
             border-bottom: 1px solid black;
−
             /* border-radius: 5px; */
+
             padding:0 3%;
 
             text-decoration: none !important;
 
             text-decoration: none !important;
 
         }
 
         }
Line 488: Line 522:
 
         div.floatCtro .daohanger {
 
         div.floatCtro .daohanger {
 
             width: 100%;
 
             width: 100%;
−
             text-align: justify !important;
+
             text-align: left !important;
−
             height: 45px;
+
             height: auto;
−
             line-height: 45px;
+
             line-height: 25px;
 
             font-family: Arial;
 
             font-family: Arial;
−
             font-size: 14px;
+
             font-size: 14px !important;
 
             color: #676767;
 
             color: #676767;
 
             margin: 0;
 
             margin: 0;
−
             padding-left: 8%;
+
             padding:10px 8%;
 
             cursor: pointer;
 
             cursor: pointer;
 
             background: #fff;
 
             background: #fff;
Line 505: Line 539:
 
             width: 100%;
 
             width: 100%;
 
             height: 40px;
 
             height: 40px;
 +
            padding:10px 8%;
 
             /* margin: 10px 0 0 0; */
 
             /* margin: 10px 0 0 0; */
 
             background: #FFF;
 
             background: #FFF;
Line 514: Line 549:
 
         div.floatCtro a span {
 
         div.floatCtro a span {
 
             display: block;
 
             display: block;
−
             height: 44px;
+
             height: auto;
−
             line-height: 44px;
+
            text-align: left !important;
 +
             line-height: 18px;
 
             font-family: Arial;
 
             font-family: Arial;
 
             font-size: 16px;
 
             font-size: 16px;
−
            padding-left: 8%;
 
 
         }
 
         }
  
Line 543: Line 578:
  
 
         .biaoti {
 
         .biaoti {
−
             line-height: 40px;
+
             display: inline-block;
−
             width: 50%;
+
            margin: 8px 0;
−
             margin-left: 6%;
+
             /* width: 50%; */
−
             text-align: center;
+
             /* margin-left: 6%; */
 +
             /* text-align: center; */
 
             text-decoration: none !important;
 
             text-decoration: none !important;
 
         }
 
         }
Line 583: Line 619:
 
         @media screen and (max-width: 1200px) {             
 
         @media screen and (max-width: 1200px) {             
 
            
 
            
 +
            .cebian {
 +
            width: 15%;
 +
            }
 +
 +
            .zhengwen {
 +
            margin: 20px 20px 0 0;
 +
 
             .daohangyi {
 
             .daohangyi {
−
                 font-size: 12px;
+
                 font-size: 14px;
 
             }
 
             }
 +
            .daohangyi img {
 +
                display: none;
 +
            } 
 
         }
 
         }
  
−
         @media screen and (max-width: 880px) {
+
         @media screen and (max-width: 900px) {
  
 
             .daohangyi img {
 
             .daohangyi img {
 
                 display: none;
 
                 display: none;
 
             }   
 
             }   
−
 
+
           
 
             .laoshi img {
 
             .laoshi img {
 
                 height: 30vh;
 
                 height: 30vh;
Line 627: Line 673:
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Improve">Improve</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Improve">Improve</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/InterLab">InterLab</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/InterLab">InterLab</a>
 +
                <a class="item" href="https://2018.igem.org/Team:HZAU-China/Notebook">Notebook</a>
 +
 
             </li>
 
             </li>
 
             <li class="hiLight shortName">
 
             <li class="hiLight shortName">
Line 641: Line 689:
 
                     <span class="xjtPic"></span>
 
                     <span class="xjtPic"></span>
 
                 </a>
 
                 </a>
−
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Safety">Safty</a>
+
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Safety">Safety</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Human_Practices">Human Practices</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Human_Practices">Human Practices</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Public_Engagement">Public Engagement</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Public_Engagement">Public Engagement</a>
Line 654: Line 702:
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Collaborations">Collaborations</a>
 
                 <a class="item" href="https://2018.igem.org/Team:HZAU-China/Collaborations">Collaborations</a>
 
             </li>
 
             </li>
−
             <li class="shortName">
+
             <li class="hiLight shortName">
−
                 <a class="nav_head" href="https://2018.igem.org/Team:HZAU-China/Parts">
+
                 <a class="nav_head" href="#">
 
                     <span>Parts</span>
 
                     <span>Parts</span>
 +
                    <span class="xjtPic"></span>
 
                 </a>
 
                 </a>
 +
                <a class="item" href="https://2018.igem.org/Team:HZAU-China/Basic_Part">Basic</a>
 +
                <a class="item" href="https://2018.igem.org/Team:HZAU-China/Composite_Part">Composite</a>
 
             </li>
 
             </li>
 
         </ul>
 
         </ul>
Line 666: Line 717:
 
         <!-- 正文 -->
 
         <!-- 正文 -->
 
         <div class="zhengwen">
 
         <div class="zhengwen">
−
            <img class="daimg" src="https://static.igem.org/mediawiki/2018/7/70/T--HZAU-China--hezhao1.png" alt="">
 
 
             <div id="float01" class="cur">
 
             <div id="float01" class="cur">
−
                 <div class="h1">biaotiyi</div>
+
                 <div class="h1">Introduction</div>
 +
                <!-- <div class="h2">Introduction</div> -->
 +
                <p>This year, we have done a lot of work in order to meet the requirement of biosafety. After
 +
                    collecting
 +
                    opinions from experts and the public, we learned that the general concerns are about: How is it
 +
                    safe to
 +
                    apply bacteriotherapy against cancer without causing unexpected damage or infection? We took these
 +
                    concerns seriously and have found some practical solutions.</p>
 +
                <div class="h2">Safety Form</div>
 +
                <p><i>Salmonella enterica</i> serovar Typhimurium str. SL1344 is not entirely harmless. In fact, the
 +
                    strain
 +
                    SL1344 which we chose for our
 +
                    project may as well cause slight enteritis. However, we chose it base on the fact that it is a
 +
                    well-learned intracellular pathogen with a lot of engineering experiences we can refer to, which is
 +
                    suitable for delivering GSDMD into cells. So we finished the Check in Form and the Safety and
 +
                    Security
 +
                    Form carefully to make sure the information is clear and intact as well as we can.</p>
 +
                <div class="h2"><i>Salmonella</i> Gene Knock out</div>
 +
                <p>Gene <i>sifA</i> is a vital gene located in <i>Salmonella</i> pathogenicity island, which increases
 +
                    the stability
 +
                    of
 +
                    <i>Salmonella</i>-Containing Vacuole (SCV) after infection. We knocked out the <i>sifA</i> gene
 +
                    from <i>Salmonella</i>
 +
                    <i>Typhimurium</i> str. SL1344 genome by conjugation transfer. The aim is to reduce the toxicity of
 +
                    <i>Salmonella</i>
 +
                    itself, then to allow the GSDMD protein, which is able to rupture the phospholipid bilayer structure,
 +
                    to be released into the cytoplasm of a tumor cell.
 +
                    After gene knock out, the strain can be easily controlled by human macrophage. See also <a href="https://2018.igem.org/Team:HZAU-China/Design">Design</a>
 +
                    and <a href="https://2018.igem.org/Team:HZAU-China/Results">Results</a>  pages for details.</p>
 +
                <div class="h2">Enhanced Targeting Specificity</div>
 +
                <p><i>Salmonella</i> has natural taxis towards tumor microenvironment. Base on the results of public
 +
                    survey
 +
                    and
 +
                    some opinions from experts, we decided to enhance the targeting specificity to a new level. We
 +
                    designed
 +
                    a new circuit to introduce OmpA-RGD protein as a surface recognition molecule, where RGD is a
 +
                    well-studied tumor homing tripeptide that binds specifically to alpha v beta 3 (αvβ3) integrin, a
 +
                    protein widely distributed on the surface of tumor cells. We successfully displayed RGD on the
 +
                    surface
 +
                    of a bacteria strain, and also proved its targeting ability towards αvβ3. See also <a href="https://2018.igem.org/Team:HZAU-China/Design">Design</a>
 +
                    and <a href="https://2018.igem.org/Team:HZAU-China/Results">Results</a> pages.</p>
  
 
             </div>
 
             </div>
 
             <div id="float02">
 
             <div id="float02">
−
                 <div class="h1">biaotier</div>
+
                 <div class="h1">Lab Safety</div>
 +
                <div class="h2">General Safety Matters</div>
 +
                <p>In our lab there is a safety training for everyone which covered the following aspects:</p>
 +
                <p>1. Personal peripheral wear: Lab coat and gloves must be worn all the time during work. Personnel
 +
                    must
 +
                    wash their hands after experiments, or before they leave the laboratory working areas. Open-toed
 +
                    footwear must not be worn in laboratories. Eating, drinking, smoking, applying cosmetics, handling
 +
                    contact lenses and sleeping are prohibited in the laboratory working areas.</p>
 +
                <p>2. Chemical safety: We printed "Dos and don'ts when using hazardous chemicals" and posted them on
 +
                    marked place. Students are trained to use dry powder extinguishers and carbon dioxide fire
 +
                    extinguishers in our lab.</p>
 +
                <p>3. GMO safety: No biological materials are allowed to be brought out of our lab. Strains must be put
 +
                    into death before dumping.</p>
 +
                <p>4. Study of guidelines: We listed some biosafety websites used for team member education:</p>
  
 +
                <div style="width: 80%; margin: 30px auto">
 +
                    <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/9/98/T--HZAU-China--safety01.jpeg" width=100% alt="">
 +
                </div>
 +
 +
                <p style="width: 100%; text-align: center !important;"><b>Figure 1.</b> Lab safety seminar</p>
 +
 +
                <p> Govern biosafety in research laboratories:<br>
 +
                    <a href="http://english.biosafety.gov.cn/">http://english.biosafety.gov.cn/</a><br><br>
 +
 +
                    Biosafety guidelines of our institution:<br>
 +
                    <a href="http://swx.hzau.edu.cn/">http://swx.hzau.edu.cn/</a> <br><br>
 +
 +
                    Regulations that govern biosafety in research laboratories:<br>
 +
                    <a href="http://english.biosafety.gov.cn/">http://english.biosafety.gov.cn/</a><br><br>
 +
                </p>
 +
 +
                <div class="h2">Our lab</div>
 +
                <p>Our lab locates in the building for School of Life Science and Technology, Huazhong Agricultural
 +
                    University. An access controlling system prevents unauthorized person from entering, and one has to
 +
                    show the student ID card to get into the door. Our biological wastes are managed by trained stuff,
 +
                    therefore
 +
                    will not enter the water body or contaminate the outside environment.</p>
 +
 +
 +
 +
                <div style="margin: 20px 0;" class="row">
 +
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/5/58/T--HZAU-China--door1.jpg"
 +
                            width="80%" alt=""></div>
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/8/8f/T--HZAU-China--door2.jpg"
 +
                            width="80%" alt="">
 +
                    </div>
 +
                </div>
 +
                <p style="width: 100%; text-align: center !important;"> <b>Figure 2.</b> Door access control</p>
 +
 +
 +
                <div class="h2">Policies</div>
 +
                <p>Here we illustrate that our 2018 project did not involve human experimentation, gene drive, use of
 +
                    animals, or use of any parts from risk group 4 organisms. Our compliance with the “Do Not Release”,
 +
                    “Deletions as Modification” and “Anti-Microbial Resistance (AMR)” policies is demonstrated above,
 +
                    as we
 +
                    always take care of what we use and never let experimental organisms with resistance plasmid or
 +
                    genome
 +
                    modification out of the lab alive without handling. As for the Human Subject Research policy, our
 +
                    survey is basically about the public’s opinions or attitude towards newly emerged cancer
 +
                    treatments,
 +
                    which barely involved any ethical issues. Nevertheless, we referred to the “Guidelines on Ethical
 +
                    Review of Biomedical Research Involving Human Subjects (NHFPC, 2016)” and the “International
 +
                    Guidelines on Market Views, Social Surveys and Data Analysis (ICC/ESOMAR, 2016)” before designing
 +
                    the
 +
                    questionnaire, for the protection of the public. All the safety rules are also obeyed; see previous
 +
                    descriptions.</p>
 +
                <div style="margin: 20px 0;" class="row">
 +
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/e/e3/T--HZAU-China--lab1.jpg"
 +
                            width="100%" alt=""></div>
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/2/26/T--HZAU-China--lab2.jpg"
 +
                            width="100%" alt="">
 +
                    </div>
 +
                </div>
 +
                <div style="margin: 20px 0;" class="row">
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/1/16/T--HZAU-China--trash.jpg"
 +
                            width="100%" alt=""></div>
 +
                    <div class="col-xs-6 col-sm-6 col-md-6 col-lg-6">
 +
                        <img style="border:8px solid #E0CCAE; box-shadow: 0 1px 3px #676767; " src="https://static.igem.org/mediawiki/2018/a/a5/T--HZAU-China--safety_fig2.jpg"
 +
                            width="100%" alt="">
 +
                    </div>
 +
 +
                </div>
 
             </div>
 
             </div>
 
             <div id="float03">
 
             <div id="float03">
−
                 <div class="h1">biaotisan</div>
+
                 <div class="h1">Reference</div>
−
                  
+
                 <p>1. Understanding Biosecurity; National research council of The National Academics, Rita r. Colwell
 +
                </p>
 +
                <p> 2. Laboratory biosecurity guidance; World Health Organization, September 2006, WHO/CDS/EPR/2006.6
 +
                </p>
 +
                <p> 3. Laboratory biosafety manual, Third edition; World Health Organization, Geneva, 2004
 +
                </p>
 
             </div>
 
             </div>
 
         </div>
 
         </div>
−
        <!-- 侧边 -->
+
    </div>
−
        <div class="cebian">
+
    <!-- 侧边 -->
−
            <!-- 滚动菜单栏 -->
+
    <div class="cebian">
−
            <div class="daohangyi">
+
        <!-- 滚动菜单栏 -->
−
                    <span class="biaoti">Safty</span>
+
        <div class="daohangyi">
−
                    <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/8/8d/T--HZAU-China--xjt.svg" alt=""></span>
+
            <span class="biaoti">Safety</span>
−
            </div>
+
            <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/8/8d/T--HZAU-China--xjt.svg" alt=""></span>
−
            <div class="floatCtro">
+
        </div>
−
                <p class="daohanger">neirongyi</p>
+
        <div class="floatCtro">
−
                <p class="daohanger">neironger</p>
+
            <p class="daohanger">Introduction</p>
−
                <p class="daohanger">neirongsan</p>
+
            <p class="daohanger">Lab Safety</p>
−
                <a>
+
            <p class="daohanger">Reference</p>
−
                    <span>Back&nbsp;to&nbsp;Top</span>
+
            <a>
−
                </a>
+
                <span>Back&nbsp;to&nbsp;Top</span>
−
            </div>
+
−
            <a class="daohangyi" href="https://2018.igem.org/Team:HZAU-China/Human_Practices">
+
−
                <span class="biaoti">Human Practices</span>
+
−
                <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/7/7c/T--HZAU-China--ysj.svg" alt=""></span>
+
 
             </a>
 
             </a>
−
            <a class="daohangyi" href="https://2018.igem.org/Team:HZAU-China/Public_Engagement">
 
−
                <span class="biaoti">Public Engagement</span>
 
−
                <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/7/7c/T--HZAU-China--ysj.svg" alt=""></span>
 
−
            </a>
 
−
            <!-- 滚动菜单栏 -->
 
 
         </div>
 
         </div>
 +
        <a class="daohangyi" href="https://2018.igem.org/Team:HZAU-China/Human_Practices">
 +
            <span class="biaoti">Human Practices</span>
 +
            <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/7/7c/T--HZAU-China--ysj.svg" alt=""></span>
 +
        </a>
 +
        <a class="daohangyi" href="https://2018.igem.org/Team:HZAU-China/Public_Engagement">
 +
            <span class="biaoti">Public Engagement</span>
 +
            <span class="xsjPic"><img src="https://static.igem.org/mediawiki/2018/7/7c/T--HZAU-China--ysj.svg" alt=""></span>
 +
        </a>
 +
        <!-- 滚动菜单栏 -->
 +
    </div>
 
     </div>
 
     </div>
  
Line 759: Line 942:
  
 
</html>
 
</html>
−
 
−
 
−
<!-- {{HZAU-China}}
 
−
<html>
 
−
 
−
 
−
<div class="column full_size">
 
−
 
−
<h1> Safety </h1>
 
−
<p>Please visit the <a href="https://2018.igem.org/Safety">Safety Hub</a> to find this year's safety requirements & deadlines, and to learn about safe & responsible research in iGEM.</p>
 
−
 
−
<p>On this page of your wiki, you should write about how you are addressing any safety issues in your project. The wiki is a place where you can <strong>go beyond the questions on the safety forms</strong>, and write about whatever safety topics are most interesting in your project. (You do not need to copy your safety forms onto this wiki page.)</p>
 
−
 
−
</div>
 
−
 
−
 
−
<div class="column two_thirds_size">
 
−
<h3>Safe Project Design</h3>
 
−
 
−
<p>Does your project include any safety features? Have you made certain decisions about the design to reduce risks? Write about them here! For example:</p>
 
−
 
−
<ul>
 
−
<li>Choosing a non-pathogenic chassis</li>
 
−
<li>Choosing parts that will not harm humans / animals / plants</li>
 
−
<li>Substituting safer materials for dangerous materials in a proof-of-concept experiment</li>
 
−
<li>Including an "induced lethality" or "kill-switch" device</li>
 
−
</ul>
 
−
 
−
</div>
 
−
 
−
<div class="column third_size">
 
−
<h3>Safe Lab Work</h3>
 
−
 
−
<p>What safety procedures do you use every day in the lab? Did you perform any unusual experiments, or face any unusual safety issues? Write about them here!</p>
 
−
 
−
 
−
<h3>Safe Shipment</h3>
 
−
 
−
<p>Did you face any safety problems in sending your DNA parts to the Registry? How did you solve those problems?</p>
 
−
</div>
 
−
 
−
 
−
</html> -->
 

Latest revision as of 03:21, 18 October 2018

Introduction

This year, we have done a lot of work in order to meet the requirement of biosafety. After collecting opinions from experts and the public, we learned that the general concerns are about: How is it safe to apply bacteriotherapy against cancer without causing unexpected damage or infection? We took these concerns seriously and have found some practical solutions.

Safety Form

Salmonella enterica serovar Typhimurium str. SL1344 is not entirely harmless. In fact, the strain SL1344 which we chose for our project may as well cause slight enteritis. However, we chose it base on the fact that it is a well-learned intracellular pathogen with a lot of engineering experiences we can refer to, which is suitable for delivering GSDMD into cells. So we finished the Check in Form and the Safety and Security Form carefully to make sure the information is clear and intact as well as we can.

Salmonella Gene Knock out

Gene sifA is a vital gene located in Salmonella pathogenicity island, which increases the stability of Salmonella-Containing Vacuole (SCV) after infection. We knocked out the sifA gene from Salmonella Typhimurium str. SL1344 genome by conjugation transfer. The aim is to reduce the toxicity of Salmonella itself, then to allow the GSDMD protein, which is able to rupture the phospholipid bilayer structure, to be released into the cytoplasm of a tumor cell. After gene knock out, the strain can be easily controlled by human macrophage. See also Design and Results pages for details.

Enhanced Targeting Specificity

Salmonella has natural taxis towards tumor microenvironment. Base on the results of public survey and some opinions from experts, we decided to enhance the targeting specificity to a new level. We designed a new circuit to introduce OmpA-RGD protein as a surface recognition molecule, where RGD is a well-studied tumor homing tripeptide that binds specifically to alpha v beta 3 (αvβ3) integrin, a protein widely distributed on the surface of tumor cells. We successfully displayed RGD on the surface of a bacteria strain, and also proved its targeting ability towards αvβ3. See also Design and Results pages.

Lab Safety
General Safety Matters

In our lab there is a safety training for everyone which covered the following aspects:

1. Personal peripheral wear: Lab coat and gloves must be worn all the time during work. Personnel must wash their hands after experiments, or before they leave the laboratory working areas. Open-toed footwear must not be worn in laboratories. Eating, drinking, smoking, applying cosmetics, handling contact lenses and sleeping are prohibited in the laboratory working areas.

2. Chemical safety: We printed "Dos and don'ts when using hazardous chemicals" and posted them on marked place. Students are trained to use dry powder extinguishers and carbon dioxide fire extinguishers in our lab.

3. GMO safety: No biological materials are allowed to be brought out of our lab. Strains must be put into death before dumping.

4. Study of guidelines: We listed some biosafety websites used for team member education:

Figure 1. Lab safety seminar

Govern biosafety in research laboratories:
http://english.biosafety.gov.cn/

Biosafety guidelines of our institution:
http://swx.hzau.edu.cn/

Regulations that govern biosafety in research laboratories:
http://english.biosafety.gov.cn/

Our lab

Our lab locates in the building for School of Life Science and Technology, Huazhong Agricultural University. An access controlling system prevents unauthorized person from entering, and one has to show the student ID card to get into the door. Our biological wastes are managed by trained stuff, therefore will not enter the water body or contaminate the outside environment.

Figure 2. Door access control

Policies

Here we illustrate that our 2018 project did not involve human experimentation, gene drive, use of animals, or use of any parts from risk group 4 organisms. Our compliance with the “Do Not Release”, “Deletions as Modification” and “Anti-Microbial Resistance (AMR)” policies is demonstrated above, as we always take care of what we use and never let experimental organisms with resistance plasmid or genome modification out of the lab alive without handling. As for the Human Subject Research policy, our survey is basically about the public’s opinions or attitude towards newly emerged cancer treatments, which barely involved any ethical issues. Nevertheless, we referred to the “Guidelines on Ethical Review of Biomedical Research Involving Human Subjects (NHFPC, 2016)” and the “International Guidelines on Market Views, Social Surveys and Data Analysis (ICC/ESOMAR, 2016)” before designing the questionnaire, for the protection of the public. All the safety rules are also obeyed; see previous descriptions.

Reference

1. Understanding Biosecurity; National research council of The National Academics, Rita r. Colwell

2. Laboratory biosecurity guidance; World Health Organization, September 2006, WHO/CDS/EPR/2006.6

3. Laboratory biosafety manual, Third edition; World Health Organization, Geneva, 2004

Safety

Introduction

Lab Safety

Reference

Back to Top
Human Practices Public Engagement